Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


Articles published in Stroke

Retrieve available abstracts of 74 articles:
HTML format



Single Articles


    November 2021
  1. BLANC C, Blanc G, Boveda S, Calviere L, et al
    Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Coexisting Cerebral Amyloid Angiopathy.
    Stroke. 2021 Nov 9:STROKEAHA121037248. doi: 10.1161/STROKEAHA.121.037248.
    PubMed    


  2. SPOSATO LA, Gurol ME
    Advances in Neurocardiology: Focus on Atrial Fibrillation.
    Stroke. 2021;52:3696-3699.
    PubMed    


    October 2021
  3. FAUCHIER L, Bisson A, Bodin A, Herbert J, et al
    Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.
    Stroke. 2021 Oct 4:STROKEAHA121034213. doi: 10.1161/STROKEAHA.121.034213.
    PubMed     Abstract available


    September 2021
  4. LEE SR, Choi EK, Park SH, Jung JH, et al
    Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation.
    Stroke. 2021 Sep 9:STROKEAHA120033338. doi: 10.1161/STROKEAHA.120.033338.
    PubMed     Abstract available


  5. PENDLEBURY ST
    Direct Oral Anticoagulants and Prevention of Dementia in Nonvalvular Atrial Fibrillation.
    Stroke. 2021 Sep 9:STROKEAHA121035664. doi: 10.1161/STROKEAHA.121.035664.
    PubMed    


    August 2021

  6. Correction to: Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation.
    Stroke. 2021;52:e523.
    PubMed    


    July 2021
  7. MEYA L, Polymeris AA, Schaedelin S, Schaub F, et al
    Oral Anticoagulants in Atrial Fibrillation Patients With Recent Stroke Who Are Dependent on the Daily Help of Others.
    Stroke. 2021 Jul 27:STROKEAHA120033862. doi: 10.1161/STROKEAHA.120.033862.
    PubMed     Abstract available


  8. REDDIN C, Judge C, Loughlin E, Murphy R, et al
    Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis.
    Stroke. 2021 Jul 20:STROKEAHA120033910. doi: 10.1161/STROKEAHA.120.033910.
    PubMed     Abstract available


  9. GRIMALDI-BENSOUDA L, Le Heuzey JY, Ferrieres J, Leys D, et al
    Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors.
    Stroke. 2021 Jul 13:STROKEAHA120032704. doi: 10.1161/STROKEAHA.120.032704.
    PubMed     Abstract available


  10. CHAN YH, Chao TF, Lee HF, Chen SW, et al
    Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Cohort Study.
    Stroke. 2021 Jul 8:STROKEAHA120033470. doi: 10.1161/STROKEAHA.120.033470.
    PubMed     Abstract available


    June 2021
  11. DING M, Wang R, Kalpouzos G, Laukka EJ, et al
    Cerebral Small Vessel Disease Associated With Atrial Fibrillation Among Older Adults: A Population-Based Study.
    Stroke. 2021 Jun 17:STROKEAHA120031573. doi: 10.1161/STROKEAHA.120.031573.
    PubMed     Abstract available


  12. MAC GRORY B, Landman SR, Ziegler PD, Boisvert CJ, et al
    Detection of Atrial Fibrillation After Central Retinal Artery Occlusion.
    Stroke. 2021 Jun 7:STROKEAHA120033934. doi: 10.1161/STROKEAHA.120.033934.
    PubMed     Abstract available


    April 2021
  13. DALMAR A, Singh M, Heis Z, Cumpian TL, et al
    Risk of Atrial Fibrillation and Stroke After Bariatric Surgery in Patients With Morbid Obesity With or Without Obstructive Sleep Apnea.
    Stroke. 2021 Apr 21:STROKEAHA120031920. doi: 10.1161/STROKEAHA.120.031920.
    PubMed     Abstract available


  14. ZHOU Z, Jardine MJ, Li Q, Neuen BL, et al
    Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
    Stroke. 2021 Apr 20:STROKEAHA120031623. doi: 10.1161/STROKEAHA.120.031623.
    PubMed     Abstract available


  15. GABET A, Guenancia C, Duloquin G, Olie V, et al
    Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry.
    Stroke. 2021 Apr 20:STROKEAHA120030812. doi: 10.1161/STROKEAHA.120.030812.
    PubMed     Abstract available


  16. PARK JH, Chung JW, Bang OY, Kim GM, et al
    Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation.
    Stroke. 2021 Apr 2:STROKEAHA120032232. doi: 10.1161/STROKEAHA.120.032232.
    PubMed     Abstract available


    March 2021
  17. STRAMBO D, Sirimarco G, Nannoni S, Perlepe K, et al
    Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Stroke. 2021 Mar 31:STROKEAHA120032453. doi: 10.1161/STROKEAHA.120.032453.
    PubMed     Abstract available


  18. PACIARONI M, Agnelli G, Giustozzi M, Caso V, et al
    Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Stroke. 2021 Mar 4:STROKEAHA120031827. doi: 10.1161/STROKEAHA.120.031827.
    PubMed     Abstract available


    February 2021
  19. DE MARCHIS GM, Sposato LA, Kuhne M, Dittrich TD, et al
    New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention.
    Stroke. 2021 Feb 25:STROKEAHA120032060. doi: 10.1161/STROKEAHA.120.032060.
    PubMed     Abstract available


  20. LABOVITZ AJ, Rose DZ, Fradley MG, Meriwether JN, et al
    Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial.
    Stroke. 2021 Feb 25:STROKEAHA120030042. doi: 10.1161/STROKEAHA.120.030042.
    PubMed     Abstract available


  21. CHEN JZ, Thijs VN
    Atrial Fibrillation Following Patent Foramen Ovale Closure: Systematic Review and Meta-Analysis of Observational Studies and Clinical Trials.
    Stroke. 2021 Feb 22:STROKEAHA120030293. doi: 10.1161/STROKEAHA.120.030293.
    PubMed     Abstract available


  22. ZHU W, Ye Z, Chen S, Wu D, et al
    Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients.
    Stroke. 2021 Feb 18:STROKEAHA120031007. doi: 10.1161/STROKEAHA.120.031007.
    PubMed     Abstract available


  23. PARK YJ, Kim JS, Park KM, On YK, et al
    Subclinical Atrial Fibrillation Burden and Adverse Clinical Outcomes in Patients With Permanent Pacemakers.
    Stroke. 2021 Feb 16:STROKEAHA120031822. doi: 10.1161/STROKEAHA.120.031822.
    PubMed     Abstract available


  24. QURESHI AI, Baskett WI, Huang W, Shyu D, et al
    Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients.
    Stroke. 2021 Feb 4:STROKEAHA120031786. doi: 10.1161/STROKEAHA.120.031786.
    PubMed     Abstract available


    January 2021
  25. HART RG
    Atrial Fibrillation and Prevention of Embolic Stroke: Personal Reflections.
    Stroke. 2021 Jan 11:STROKEAHA120030420. doi: 10.1161/STROKEAHA.120.030420.
    PubMed    


  26. LEE SR, Choi EK, Jung JH, Park SH, et al
    Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.
    Stroke. 2021 Jan 11:STROKEAHA120030356. doi: 10.1161/STROKEAHA.120.030356.
    PubMed     Abstract available


  27. KWON S, Lee SR, Choi EK, Lee E, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.
    Stroke. 2021 Jan 8:STROKEAHA120030761. doi: 10.1161/STROKEAHA.120.030761.
    PubMed     Abstract available


    December 2020
  28. KOSHY AN, Enyati A, Weinberg L, Han HC, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation.
    Stroke. 2020 Dec 22:STROKEAHA120031454. doi: 10.1161/STROKEAHA.120.031454.
    PubMed     Abstract available


  29. AGUIAR DE SOUSA D, Katan M
    Promising Use of Automated Electronic Phenotyping: Turning Big Data Into Big Value in Stroke Research.
    Stroke. 2020 Dec 10:STROKEAHA120033061. doi: 10.1161/STROKEAHA.120.033061.
    PubMed    


  30. GUAN W, Ko D, Khurshid S, Trisini Lipsanopoulos AT, et al
    Automated Electronic Phenotyping of Cardioembolic Stroke.
    Stroke. 2020 Dec 10:STROKEAHA120030663. doi: 10.1161/STROKEAHA.120.030663.
    PubMed     Abstract available


  31. HUSSEIN HM, Anderson DC
    Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation?
    Stroke. 2020 Dec 7:STROKEAHA120032536. doi: 10.1161/STROKEAHA.120.032536.
    PubMed    


  32. DU H, Wilson D, Ambler G, Banerjee G, et al
    Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
    Stroke. 2020 Dec 7:STROKEAHA120029474. doi: 10.1161/STROKEAHA.120.029474.
    PubMed     Abstract available


  33. PENGO MF, Faini A, Grote L, Ludka O, et al
    Impact of Sleep Apnea on Cardioembolic Risk in Patients With Atrial Fibrillation: Data From the ESADA Cohort.
    Stroke. 2020 Dec 4:STROKEAHA120030285. doi: 10.1161/STROKEAHA.120.030285.
    PubMed     Abstract available


  34. WETMORE JB, Roetker NS, Herzog CA
    Response by Wetmore et al to Letter Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".
    Stroke. 2020;51:e363-e364.
    PubMed    


  35. DING WY, Rivera-Caravaca JM, Lip GYH
    Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".
    Stroke. 2020;51:e361-e362.
    PubMed    


    November 2020
  36. SENADEERA SC, Palmer DG, Keenan R, Beharry J, et al
    Left Atrial Appendage Thrombus Detected During Hyperacute Stroke Imaging Is Associated With Atrial Fibrillation.
    Stroke. 2020 Nov 9:STROKEAHA120030258. doi: 10.1161/STROKEAHA.120.030258.
    PubMed     Abstract available


    October 2020
  37. SPENCE JD, Azarpazhooh MR, Larsson SC, Bogiatzi C, et al
    Stroke Prevention in Older Adults: Recent Advances.
    Stroke. 2020 Oct 30:STROKEAHA120031707. doi: 10.1161/STROKEAHA.120.031707.
    PubMed     Abstract available


  38. GROSSE GM, Sieweke JT, Biber S, Ziegler NL, et al
    Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source: Interplay of Arterial and Atrial Disease.
    Stroke. 2020 Oct 12:STROKEAHA120030537. doi: 10.1161/STROKEAHA.120.030537.
    PubMed     Abstract available


  39. HAAS K, Rucker V, Hermanek P, Misselwitz B, et al
    Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke.
    Stroke. 2020 Oct 12:STROKEAHA120029968. doi: 10.1161/STROKEAHA.120.029968.
    PubMed     Abstract available


  40. ZHOU E, Lord A, Boehme A, Henninger N, et al
    Risk of Ischemic Stroke in Patients With Atrial Fibrillation After Extracranial Hemorrhage.
    Stroke. 2020 Oct 8:STROKEAHA120029959. doi: 10.1161/STROKEAHA.120.029959.
    PubMed     Abstract available


  41. CHOI KH, Kim JH, Lee C, Kim JM, et al
    Microbleeds and Outcome in Patients With Acute Ischemic Stroke and Atrial Fibrillation Taking Anticoagulants.
    Stroke. 2020 Oct 8:STROKEAHA120030300. doi: 10.1161/STROKEAHA.120.030300.
    PubMed     Abstract available


    September 2020
  42. ELKIND MSV, Boehme AK, Smith CJ, Meisel A, et al
    Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.
    Stroke. 2020 Sep 8:STROKEAHA120030429. doi: 10.1161/STROKEAHA.120.030429.
    PubMed     Abstract available



  43. Correction to: Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
    Stroke. 2020;51:e271.
    PubMed    


    August 2020
  44. JUNG YH, Kim YD, Kim J, Han SW, et al
    Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Stroke. 2020 Aug 19:STROKEAHA120030138. doi: 10.1161/STROKEAHA.120.030138.
    PubMed     Abstract available


  45. KAMEL H, Navi BB, Parikh NS, Merkler AE, et al
    Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source.
    Stroke. 2020 Aug 12:STROKEAHA120029305. doi: 10.1161/STROKEAHA.120.029305.
    PubMed     Abstract available


  46. NGUYEN-HUYNH MN, Tang XN, Vinson DR, Flint AC, et al
    Acute Stroke Presentation, Care, and Outcomes in Community Hospitals in Northern California During the COVID-19 Pandemic.
    Stroke. 2020 Aug 7:STROKEAHA120031099. doi: 10.1161/STROKEAHA.120.031099.
    PubMed     Abstract available


  47. SEIFFGE DJ, Goeldlin M
    Art of Anticoagulation After Recent Ischemic Stroke.
    Stroke. 2020 Aug 6:STROKEAHA120030997. doi: 10.1161/STROKEAHA.120.030997.
    PubMed    


  48. YAGHI S, Mistry E, Liberman AL, Giles J, et al
    Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.
    Stroke. 2020 Aug 6:STROKEAHA120028867. doi: 10.1161/STROKEAHA.120.028867.
    PubMed     Abstract available


    July 2020
  49. GIUSTOZZI M, Acciarresi M, Agnelli G, Caso V, et al
    Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.
    Stroke. 2020 Jul 10:STROKEAHA120030143. doi: 10.1161/STROKEAHA.120.030143.
    PubMed     Abstract available


  50. WETMORE JB, Roetker NS, Yan H, Reyes JL, et al
    Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation.
    Stroke. 2020 Jul 9:STROKEAHA120028934. doi: 10.1161/STROKEAHA.120.028934.
    PubMed     Abstract available


  51. ONG E, Meseguer E, Guidoux C, Lavallee PC, et al
    Prevalence and Outcome of Potential Candidates for Left Atrial Appendage Closure After Stroke With Atrial Fibrillation: WATCH-AF Registry.
    Stroke. 2020 Jul 9:STROKEAHA120029267. doi: 10.1161/STROKEAHA.120.029267.
    PubMed     Abstract available


    June 2020
  52. TANAKA K, Koga M, Bae HJ
    Response by Tanaka et al to Letter Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Stroke. 2020 Jun 26:STROKEAHA120030414. doi: 10.1161/STROKEAHA.120.030414.
    PubMed    


  53. HSIEH CY, Sung SF
    Letter by Hsieh and Sung Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Stroke. 2020 Jun 26:STROKEAHA120030101. doi: 10.1161/STROKEAHA.120.030101.
    PubMed    


  54. VAN GANSE E, Danchin N, Mahe I, Hanon O, et al
    Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
    Stroke. 2020 Jun 16:STROKEAHA120028825. doi: 10.1161/STROKEAHA.120.028825.
    PubMed     Abstract available


  55. MENTIAS A, Heller E, Vaughan Sarrazin M
    Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy.
    Stroke. 2020 Jun 10:STROKEAHA120029541. doi: 10.1161/STROKEAHA.120.029541.
    PubMed     Abstract available


  56. CHEW DS, Rennert-May E, Spackman E, Mark DB, et al
    Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review.
    Stroke. 2020 Jun 5:STROKEAHA120029340. doi: 10.1161/STROKEAHA.120.029340.
    PubMed     Abstract available


    May 2020
  57. KRITTAYAPHONG R, Winijkul A, Kunjara-Na-Ayudhya R, Apiyasawat S, et al
    Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
    Stroke. 2020 May 11:STROKEAHA120029295. doi: 10.1161/STROKEAHA.120.029295.
    PubMed     Abstract available


  58. BODIN A, Bisson A, Gaborit C, Herbert J, et al
    Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions.
    Stroke. 2020 May 11:STROKEAHA120029048. doi: 10.1161/STROKEAHA.120.029048.
    PubMed     Abstract available



  59. Correction to: Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.
    Stroke. 2020;51:e100.
    PubMed    



  60. Correction to: Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Stroke. 2020;51:e99.
    PubMed    


  61. MURTHY SB, Wu X, Diaz I, Parasram M, et al
    Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.
    Stroke. 2020;51:1464-1469.
    PubMed     Abstract available


    April 2020
  62. LEE SR, Choi EK, Lip GYH
    Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029551. doi: 10.1161/STROKEAHA.120.029551.
    PubMed    


  63. LIANG B, Zhao YX, Gu N
    Letter by Liang et al Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029434. doi: 10.1161/STROKEAHA.120.029434.
    PubMed    


  64. KOKKINIDIS DG, Zareifopoulos N, Theochari CA, Arfaras-Melainis A, et al
    Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis.
    Stroke. 2020 Apr 21:STROKEAHA119027815. doi: 10.1161/STROKEAHA.119.027815.
    PubMed     Abstract available


  65. MCMAHON NE, Bangee M, Benedetto V, Bray EP, et al
    Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.
    Stroke. 2020 Apr 13:STROKEAHA119027123. doi: 10.1161/STROKEAHA.119.027123.
    PubMed     Abstract available


  66. KHURSHID S, Trinquart L, Weng LC, Hulme OL, et al
    Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.
    Stroke. 2020 Apr 7:STROKEAHA120028837. doi: 10.1161/STROKEAHA.120.028837.
    PubMed     Abstract available


    March 2020
  67. ANDREASEN C, Gislason GH, Kober L, Abdulla J, et al
    Incidence of Ischemic Stroke in Individuals With and Without Aortic Valve Stenosis: A Danish Retrospective Cohort Study.
    Stroke. 2020 Mar 27:STROKEAHA119028389. doi: 10.1161/STROKEAHA.119.028389.
    PubMed     Abstract available


  68. BEHARRY J, Waters MJ, Drew R, Fink JN, et al
    Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Stroke. 2020 Mar 25:STROKEAHA119028327. doi: 10.1161/STROKEAHA.119.028327.
    PubMed     Abstract available


    February 2020
  69. CAO S, Wang J, Xia M
    Letter by Cao et al Regarding Article, "Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke".
    Stroke. 2020 Feb 26:STROKEAHA119028801. doi: 10.1161/STROKEAHA.119.028801.
    PubMed    


    January 2020
  70. OLIVIERI O, Cappellari M, Turcato G, Bonetti B, et al
    Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
    Stroke. 2020;51:61-68.
    PubMed     Abstract available


  71. MURTHY SB, Diaz I, Wu X, Merkler AE, et al
    Risk of Arterial Ischemic Events After Intracerebral Hemorrhage.
    Stroke. 2020;51:137-142.
    PubMed     Abstract available


  72. GUTIERREZ J, Gil-Guevara A, Ramaswamy S, DeRosa J, et al
    Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events.
    Stroke. 2020;51:90-98.
    PubMed     Abstract available


    December 2019
  73. SHAHJOUEI S, Tsivgoulis G, Goyal N, Sadighi A, et al
    Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
    Stroke. 2019 Dec 30:STROKEAHA119026426. doi: 10.1161/STROKEAHA.119.026426.
    PubMed     Abstract available


    September 2019
  74. LERARIO MP, Grotta JC, Merkler AE, Omran SS, et al
    Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke.
    Stroke. 2019 Sep 13:STROKEAHA119026861. doi: 10.1161/STROKEAHA.119.026861.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: